MedTrace Logo

Evaluation of FeNO During and Following Acute COPD Exacerbation

NCT01761006 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2017-11-07

No results posted yet for this study

Summary

The purpose of this research study is to determine whether exhaled nitric oxide (FeNO) goes up during an acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) and whether the level of exhaled nitric oxide returns to normal in the weeks after an exacerbation.

Conditions

Interventions

DEVICE

NIOX MINO®

Sponsors & Collaborators

  • Aerocrine AB

    collaborator INDUSTRY

  • Wake Forest University

    lead OTHER

Principal Investigators

  • Jill Ohar, MD · Wake Forest University Health Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-09-23
Completion
2014-09-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01761006 on ClinicalTrials.gov